• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Guidelines for medical devices registration in China – New development plans in 2023

Guidelines for medical devices registration in China – New development plans in 2023

guidelines for medical devices registration
Friday, 12 May 2023 / Published in Medical Device, News, NMPA Registration in China

Guidelines for medical devices registration in China – New development plans in 2023

Guidelines for medical devices registration in China have new development plans released by the Center for Medical Device Evaluation (CMDE) under the National Medical Products Administration (NMPA) on April 4, 2023.

The development plans cover the new implementation and amendments of technical review guidelines for class II and III medical devices in China. For both class II and III medical devices, the CMDE released a list of 59 new technical review guidelines to be implemented and 59 existing technical review guidelines to be revised.

Guidelines for Class III medical devices

  • According to the CMDE, 36 guidelines will be developed for the technical review of registration applications for class III medical devices including but not limited to the following:
    • Nitric oxide therapy instrument registration review guidelines
    • ECMO system clinical evaluation registration review guidelines
    • HLA-B27 gene test registration review guidelines
    • Hydrogel dressing product registration review guidelines
    • Antibiotic drug sensitivity testing reagents registration review guidelines
  • Moreover, 27 existing guidelines will be revised for class III medical devices. Here are some of the guidelines being covered for reference:
    • Mobile medical device registration review guidelines
    • High frequency surgical devices registration review guidelines
    • Classification of medical device registration units guidelines

Guidelines for Class II medical devices

  • CMDE also plans to develop 23 guidelines for the registration review of class II medical devices. The list of technical review guidelines cover but are not limited to the following:
    • Rehabilitation training bed registration review guidelines
    • Medical gas alarm system registration review guidelines
    • Electrolyte analyzer registration review guidelines
    • Laser positioning system product registration review guidelines
    • Nebulizer mask product registration review guidelines
  • 32 existing guidelines for class II medical devices registration review are announced in the development plans. Some of these technical review guidelines cover:
    • X-ray diagnostic equipment (class II) registration review guidelines
    • Electronic blood pressure monitor (oscillometric method) registration review guidelines
    • Urine Analyzer Registration Review Guidelines

In recent years, the CMDE has continued to promote the formulation and revision of medical registration review guidelines. China’s medical devices registration management technical support system continues to improve, and medical device product safety and effectiveness evaluation tools are becoming increasingly mature. As of 2022, 529 medical devices registration review guidelines have been issued.

Further information

Read the original CMDE announcement on the development plans for the new implementation and amendments of technical review guidelines for medical devices registration in 2023.

Discover our services for medical device registration, renewals and NMPA Legal Agent.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

What information needs to be provided when applying for a change in the packaging specifications of in vitro diagnostic reagents?
NIFDC Launches Public Consultation on Banning CBD as Cosmetics Ingredient
Overseas Innovative Medical Device Fast-Track Approval
Second Overseas Innovative Medical Device in 2020 Approved via Green Channel

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...
  • China chemical drug instructions labels

    China chemical drug instructions and labels guidelines

    The guidelines for writing pharmacology-related...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP